|
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
|
Life Sciences & Biotechnology
|
All India Institute of Medical Sciences
|
Gilead Sciences, Inc., USA
|
2017
|
Completed
|
|
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)
|
Life Sciences & Biotechnology
|
All India Institute of Medical Sciences
|
Gilead Sciences, Inc., USA
|
2017
|
Completed
|
|
A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Adolescents with Chronic Hepatitis B Virus Infection
|
Life Sciences & Biotechnology
|
All India Institute of Medical Sciences
|
Gilead Sciences, Inc., USA
|
2017
|
Completed
|
|
Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to severely active crohn?s disease
|
Life Sciences & Biotechnology
|
All India Institute of Medical Sciences
|
Gilead Sciences, Inc., USA
|
2017
|
Completed
|
|
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to sever active ulcerative colitis
|
Life Sciences & Biotechnology
|
All India Institute of Medical Sciences
|
Gilead Sciences, Inc., USA
|
2017
|
Completed
|
|
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis
|
Life Sciences & Biotechnology
|
All India Institute of Medical Sciences
|
Gilead Sciences, Inc., USA
|
2017
|
Completed
|
|
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohns Disease
|
Life Sciences & Biotechnology
|
All India Institute of Medical Sciences
|
Gilead Sciences, Inc., USA
|
2017
|
Completed
|
|
ENT COBRA: Standarized Data Collection (SDC) for head neck cancer patients treated with brachytherapy
|
Life Sciences & Biotechnology
|
Tata Memorial Hospital (TMC), Maharashtra
|
European Society for Radiotherapy & Oncology (GEC - ESTRO), Belgium
|
2017
|
Completed
|
|
Strengthening/promoting evidence-based advocacy for influenza prevention and control in India
|
Life Sciences & Biotechnology
|
All India Institute of Medical Sciences
|
Centers for Disease Control and Prevention (CDC), Atlanta, USA
|
2017
|
Completed
|
|
Digital pathology based low-cost outcome predictor for ER+ Breast Cancers
|
Life Sciences & Biotechnology
|
Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai, Maharashtra
|
Case Western Reserve University (CWRU), USA
|
2017
|
Completed
|